The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Employment - Hookipa Pharma
Stock and Other Ownership Interests - Hookipa Pharma
First report of the safety/tolerability and preliminary antitumor activity of HB-201 and HB-202, an arenavirus-based cancer immunotherapy, in patients with HPV16+ cancers.
 
Alan Loh Ho
Consulting or Advisory Role - AffyImmune Therapeutics; AstraZeneca; Ayala Pharmaceuticals; Bristol-Myers Squibb; CureVac; CureVac; Eisai; Eisai; Exelixis; Genzyme; Kura Oncology; McGivney Global Advisors; Merck; Novartis; Prelude Therapeutics; Regeneron; Rgenta; Sanofi; Sun Pharma; TRM Oncology
Speakers' Bureau - Medscape; Novartis; Omniprex America
Research Funding - Allos Therapeutics; Astellas Pharma; AstraZeneca; AstraZeneca; AstraZeneca; AstraZeneca; Ayala Pharmaceuticals; Ayala Pharmaceuticals; Bayer; Bayer; Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; Daiichi Sankyo; Eisai; Elevar Therapeutics; Genentech/Roche; Kolltan Pharmaceuticals; Kura Oncology; Lilly; Merck; Novartis; Novartis; Novartis; Pfizer
Travel, Accommodations, Expenses - Ayala Pharmaceuticals; Ignyta; Janssen Oncology; Klus Pharma; Kura Oncology; Kura Oncology; Kura Oncology; Merck
 
Marshall R. Posner
Consulting or Advisory Role - BioNTech; Cel-Sci; Kura Oncology; Merck; Naveris
Research Funding - advaxis (Inst); AstraZeneca (Inst); Formation Biologics (Inst); Hookipa Pharma (Inst); Innate Pharma (Inst); MedImmune (Inst); Regeneron (Inst)
Patents, Royalties, Other Intellectual Property - anti-Pseudomonas antibody (Inst); anti-Staphylococcal Monoclonal antibody (Inst); Uptodate editor
(OPTIONAL) Uncompensated Relationships - My Personal Therapeutics
 
Jiaxin Niu
Consulting or Advisory Role - AstraZeneca; Boehringer Ingelheim; Boehringer Ingelheim; Immvira; Merck; OncLive Clinical Congress Consultants
 
Siqing Fu
Research Funding - Abbisko (Inst); Anaeropharma (Inst); Arrien Pharmaceuticals (Inst); AstraZeneca (Inst); BeiGene (Inst); BioAtla (Inst); Boehringer Ingelheim (Inst); Hookipa Pharma (Inst); Huya Bioscience International (Inst); IMV (Inst); Innovent Biologics (Inst); Lilly (Inst); Lyvgen Biopharma (Inst); MacroGenics (Inst); Medivir (Inst); Millennium (Inst); NCCN (Inst); NCCN (Inst); Nerviano Medical Sciences (Inst); NeuPharma, Inc. (Inst); NIH/NCI (Inst); Novartis (Inst); NovoCure (Inst); OncoMed (Inst); Parexel International, LLC (Inst); Sellas Life Sciences (Inst); Soricimed (Inst); Taiho Oncology (Inst); Tolero Pharmaceuticals (Inst); Turnstone Bio (Inst)
 
Rom S. Leidner
Consulting or Advisory Role - Merck
Research Funding - Bristol-Myers Squibb; Bristol-Myers Squibb (Inst)
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Merck; Sanofi
 
Alexander T. Pearson
Stock and Other Ownership Interests - Inovalon (I)
Consulting or Advisory Role - Prelude Therapeutics
 
Ki Y. Chung
Consulting or Advisory Role - Genentech
Research Funding - MedImmune (Inst)
 
Debra L. Richardson
Consulting or Advisory Role - AstraZeneca; Bayer; Deciphera; Foundation Medicine; Genentech/Roche; GlaxoSmithKline; Ipsen; Mersana; Tesaro
Research Funding - Aravive (Inst); ArQule (Inst); AstraZeneca (Inst); Deciphera (Inst); Five Prime Therapeutics (Inst); Fujifilm (Inst); Genentech (Inst); Harpoon therapeutics (Inst); Hookipa Biotech (Inst); Innovent Biologics (Inst); Karyopharm Therapeutics (Inst); Lycera (Inst); Merck (Inst); Mersana (Inst); Roche (Inst); Syros Pharmaceuticals (Inst); Tesaro (Inst)
 
Ding Wang
Travel, Accommodations, Expenses - Qurgen
 
Agustin Pimentel
Stock and Other Ownership Interests - BioNTech; Pfizer
Consulting or Advisory Role - Bristol-Myers Squibb; QED Therapeutics; Taiho Oncology
Research Funding - Hookipa Biotech; Isofol Medical; Ludwig Institute for Cancer Research; Turnstone Bio
 
Jorge J. Nieva
Stock and Other Ownership Interests - Cansera; Epic Sciences; Indee P/L; Quantgene
Consulting or Advisory Role - AstraZeneca; Fujirebio Diagnostics; Naveris
Research Funding - Merck
Patents, Royalties, Other Intellectual Property - Patent Pending - movement and unexpected healthcare encounters
 
Ari Rosenberg
Consulting or Advisory Role - EMD Serono; Nanobiotix
 
Bharat Burman
Employment - Janssen (I)
Stock and Other Ownership Interests - Janssen (I)
 
Corinne Iacobucci
Employment - Daiichi Sankyo; Hookipa Pharma
Stock and Other Ownership Interests - Bristol-Myers Squibb
Consulting or Advisory Role - Daiichi Sankyo
Other Relationship - Moderna Therapeutics
 
Xiaoping Qing
No Relationships to Disclose
 
Andy Hwang
Employment - Hookipa Pharma
Leadership - Hookipa Pharma
Stock and Other Ownership Interests - Hookipa Pharma
 
Kia Katchar
Employment - Hookipa Pharma
Stock and Other Ownership Interests - Hookipa Pharma
 
Katia Schlienger
Employment - Hookipa Pharma; Merck
Stock and Other Ownership Interests - Hookipa Pharma; Merck
Travel, Accommodations, Expenses - Hookipa Pharma; Merck
 
Igor Matushansky
Employment - Hookipa Pharma
Leadership - Crescendo Biologics
Stock and Other Ownership Interests - Hookipa Pharma
Travel, Accommodations, Expenses - Hookipa Pharma
Other Relationship - Hookipa Pharma
 
David G. Pfister
Consulting or Advisory Role - Boehringer Ingelheim; Incyte
Research Funding - AstraZeneca (Inst); Atara Biotherapeutics (Inst); Bayer (Inst); Boehringer Ingelheim (Inst); Eisai (Inst); Exelixis (Inst); Genentech/Roche (Inst); Hookipa Pharma (Inst); Lilly (Inst); MedImmune (Inst); MeiraGTx (Inst); Merck (Inst); Novartis (Inst); Regeneron (Inst)